rs372235519
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007059.4(KPTN):c.1250G>A(p.Arg417His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_007059.4 missense
Scores
Clinical Significance
Conservation
Publications
- macrocephaly-developmental delay syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KPTN | NM_007059.4 | c.1250G>A | p.Arg417His | missense_variant | Exon 12 of 12 | ENST00000338134.8 | NP_008990.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152224Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000121 AC: 3AN: 248534 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461174Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726846 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152224Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Macrocephaly-developmental delay syndrome Uncertain:1
This sequence change replaces arginine with histidine at codon 417 of the KPTN protein (p.Arg417His). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs372235519, ExAC 0.01%). This variant has not been reported in the literature in individuals with KPTN-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The histidine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1250G>A (p.R417H) alteration is located in exon 12 (coding exon 12) of the KPTN gene. This alteration results from a G to A substitution at nucleotide position 1250, causing the arginine (R) at amino acid position 417 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at